- Home
- ASPN vs SVRA Comparison
ASPN vs SVRA Comparison
Compare ASPN & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- SVRA
- Stock Information
- Founded
- ASPN 2001
- SVRA 2007
- Country
- ASPN United States
- SVRA United States
- Employees
- ASPN N/A
- SVRA N/A
- Industry
- ASPN RETAIL: Building Materials
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- ASPN Consumer Discretionary
- SVRA Health Care
- Exchange
- ASPN Nasdaq
- SVRA Nasdaq
- Market Cap
- ASPN 486.5M
- SVRA 528.3M
- IPO Year
- ASPN 2014
- SVRA N/A
- Fundamental
- Price
- ASPN $6.49
- SVRA $2.32
- Analyst Decision
- ASPN Strong Buy
- SVRA Buy
- Analyst Count
- ASPN 10
- SVRA 5
- Target Price
- ASPN $21.78
- SVRA $5.60
- AVG Volume (30 Days)
- ASPN 1.6M
- SVRA 1.4M
- Earning Date
- ASPN 08-06-2025
- SVRA 08-11-2025
- Dividend Yield
- ASPN N/A
- SVRA N/A
- EPS Growth
- ASPN N/A
- SVRA N/A
- EPS
- ASPN N/A
- SVRA N/A
- Revenue
- ASPN $436,921,000.00
- SVRA N/A
- Revenue This Year
- ASPN N/A
- SVRA N/A
- Revenue Next Year
- ASPN $24.31
- SVRA N/A
- P/E Ratio
- ASPN N/A
- SVRA N/A
- Revenue Growth
- ASPN 51.90
- SVRA N/A
- 52 Week Low
- ASPN $4.16
- SVRA $1.89
- 52 Week High
- ASPN $33.15
- SVRA $5.03
- Technical
- Relative Strength Index (RSI)
- ASPN 57.77
- SVRA 55.49
- Support Level
- ASPN $6.53
- SVRA $2.24
- Resistance Level
- ASPN $7.18
- SVRA $2.50
- Average True Range (ATR)
- ASPN 0.36
- SVRA 0.16
- MACD
- ASPN 0.06
- SVRA 0.06
- Stochastic Oscillator
- ASPN 73.97
- SVRA 83.03
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.